Australia markets closed

Pharming Group N.V. (PHAR)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
10.00+0.60 (+6.38%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
30,367
-10,548
13,674
15,996
37,746
Depreciation & amortisation
18,959
15,925
13,188
19,610
8,314
Stock-based compensation
7,872
9,251
6,392
9,056
6,537
Change in working capital
-3,240
-16,961
-387
-4,961
-3,916
Inventory
-8,408
-14,434
-15,016
-6,153
-4,934
Other working capital
25,366
-18,766
20,481
21,126
68,326
Other non-cash items
-8,335
4,327
-598
-8,186
30,971
Net cash provided by operating activities
33,156
-17,302
22,458
37,842
83,626
Cash flows from investing activities
Investments in property, plant and equipment
-7,790
-1,464
-1,977
-16,716
-15,300
Acquisitions, net
-
-
-
0
-329
Purchases of investments
0
-382,014
0
-4,589
0
Sales/maturities of investments
232,811
232,811
0
0
-
Other investing activities
21,279
21,279
-
-
-
Net cash used for investing activities
-406
-129,388
5,323
-21,305
-15,629
Cash flows from financing activities
Debt repayment
-3,126
-5,126
-3,311
-3,217
-59,417
Common stock issued
1,605
-
2,281
4,718
2,791
Dividends paid
0
0
0
0
0
Other financing activities
-
-
-
-25,000
-23,371
Net cash used provided by (used for) financing activities
-5,475
-1,039
-4,982
-27,947
60,686
Net change in cash
27,275
-147,729
22,799
-11,410
128,683
Cash at beginning of period
183,324
207,342
191,924
205,159
74,348
Cash at end of period
210,599
61,741
207,342
191,924
205,159
Free cash flow
Operating cash flow
33,156
-17,302
22,458
37,842
83,626
Capital expenditure
-7,790
-1,464
-1,977
-16,716
-15,300
Free cash flow
25,366
-18,766
20,481
21,126
68,326